NJIT to start programs in cell and gene therapy
The New Jersey Institute of Technology will collaborate with the New Jersey Innovation Institute, an NJIT corporation, to offer a professional science master’s degree program and professional graduate certificate in the rapidly expanding field of cell and gene therapy.
Students be able to begin taking the 30-credit master’s degree in spring 2020 as part of NJIT’s Department of Chemistry and Environmental Science’s pharmaceutical chemistry master’s program.
NJIT says this is a four-course certificate program for anyone who is seeking training in cutting-edge technologies required for processing and commercializing of new therapies.
Hands-on training in the field’s newest approaches and technologies will be supported at NJIT’s labs and at The New Jersey Innovation Institute’s Cell and Gene Therapy Development Center. NJII says the center will upgrade the knowledge and skills of bio-pharmaceutical professionals in the processing of new, breakthrough classes of biologic therapies.
Both programs were developed to meet growing demands from the bio-pharmaceutical industry for trained scientists and engineers at the forefront of the coming wave of breakthrough gene and cell therapies, including advanced gene delivery technologies to immunotherapies such as CAR-T cancer therapy.